1. Home
  2. SNDX vs MOMO Comparison

SNDX vs MOMO Comparison

Compare SNDX & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • MOMO
  • Stock Information
  • Founded
  • SNDX 2005
  • MOMO 2011
  • Country
  • SNDX United States
  • MOMO China
  • Employees
  • SNDX N/A
  • MOMO N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • MOMO Computer Software: Prepackaged Software
  • Sector
  • SNDX Health Care
  • MOMO Technology
  • Exchange
  • SNDX Nasdaq
  • MOMO Nasdaq
  • Market Cap
  • SNDX 1.1B
  • MOMO 1.2B
  • IPO Year
  • SNDX 2016
  • MOMO 2014
  • Fundamental
  • Price
  • SNDX $13.08
  • MOMO $7.23
  • Analyst Decision
  • SNDX Strong Buy
  • MOMO Buy
  • Analyst Count
  • SNDX 10
  • MOMO 3
  • Target Price
  • SNDX $36.20
  • MOMO $8.67
  • AVG Volume (30 Days)
  • SNDX 2.6M
  • MOMO 967.3K
  • Earning Date
  • SNDX 02-25-2025
  • MOMO 03-13-2025
  • Dividend Yield
  • SNDX N/A
  • MOMO 7.47%
  • EPS Growth
  • SNDX N/A
  • MOMO N/A
  • EPS
  • SNDX N/A
  • MOMO 0.98
  • Revenue
  • SNDX $16,000,000.00
  • MOMO $1,558,116,328.00
  • Revenue This Year
  • SNDX N/A
  • MOMO N/A
  • Revenue Next Year
  • SNDX $14.15
  • MOMO N/A
  • P/E Ratio
  • SNDX N/A
  • MOMO $7.40
  • Revenue Growth
  • SNDX N/A
  • MOMO N/A
  • 52 Week Low
  • SNDX $12.06
  • MOMO $4.79
  • 52 Week High
  • SNDX $25.34
  • MOMO $8.19
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 41.29
  • MOMO 53.57
  • Support Level
  • SNDX $12.40
  • MOMO $6.63
  • Resistance Level
  • SNDX $13.16
  • MOMO $7.76
  • Average True Range (ATR)
  • SNDX 0.65
  • MOMO 0.26
  • MACD
  • SNDX 0.10
  • MOMO -0.03
  • Stochastic Oscillator
  • SNDX 39.38
  • MOMO 53.10

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About MOMO Hello Group Inc.

Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines out of which Momo's service lines segment derives the majority of revenue.

Share on Social Networks: